Literature DB >> 32611918

First confirmed case of COVID-19 infection in India: A case report.

M A Andrews1, Binu Areekal2, K R Rajesh3, Jijith Krishnan3, R Suryakala4, Biju Krishnan5, C P Muraly6, P V Santhosh5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32611918      PMCID: PMC7530459          DOI: 10.4103/ijmr.IJMR_2131_20

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Sir, Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East respiratory syndrome (MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV1. On December 31, 2019, China informed the World Health Organization (WHO) about cases of pneumonia of unknown aetiology detected in Wuhan city, Hubei province of China. From December 31, 2019 to January 3, 2020, a total of 44 patients with pneumonia of unknown aetiology were reported to the WHO by the national authorities in China2. During this period, the causal agent was not identified. The cases initially identified had a history of exposure to the Huanan Seafood Wholesale Market3. The most common clinical features of the early clinical cases from Wuhan, China, were fever (98.6%), fatigue (69.6%) and dry cough (59.4%)4. The second meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (2005) regarding the outbreak of novel coronavirus 2019 in the People's Republic of China on January 30, 2020, declared COVID-19 outbreak as Public Health Emergency of International Concern (PHEIC)5. As on February 17, 2020, except China, 25 other countries have been affected by COVID-19 outbreak with 70,635 confirmed cases and 1,772 deaths in China. Outside China, 794 cases were reported with three deaths6. We present here the first case of COVID-19 infection reported in Kerala, India. On January 27, 2020, a 20 yr old female presented to the Emergency Department in General Hospital, Thrissur, Kerala, with a one-day history of dry cough and sore throat. There was no history of fever, rhinitis or shortness of breath. She disclosed that she had returned to Kerala from Wuhan city, China, on January 23, 2020 owing to COVID-19 outbreak situation there. She was asymptomatic between January 23 and 26. On the 27th morning, she felt a mild sore throat and dry cough. She did not give a history of contact with a person suspected or confirmed with COVID-19 infection. She did not visit the Huanan Seafood Wholesale Market, however, she gave a history of travel from Wuhan to Kunming by train where she noticed people with respiratory symptoms in railway station and train. She received the instructions from the Kerala State authorities to visit a healthcare facility if she develops any symptoms because of the travel history to China. In the Emergency department in General Hospital, she was afebrile with a pulse rate of 82/min, blood pressure 130/80 mmHg, temperature 98.5°F and oxygen saturation 96 per cent while the patient was breathing ambient air. Lung auscultation revealed normal breath sounds with no adventitious sounds. In view of her travel history from Wuhan, the district rapid response team decided to admit her in an isolation room which was designated for the corona epidemic. An oropharyngeal swab was obtained and was sent to the ICMR-National Institute of Virology (NIV), Pune, for the detection of viral respiratory pathogens on January 27, 2020. Three millilitres each of EDTA blood and plain blood samples were also collected and sent to NIV, Pune, where COVID-19 was diagnosed using real time reverse transcription PCR. Specimen collection was done on day 0 (admission) and every alternate day. Urine and stool samples were also sent for detailed evaluation. She was started on azithromycin (500 mg), cetirizine (10 mg) and saline gargle. Over the next three days, her symptoms improved. Her oropharyngeal swab result was reported by the NIV, Pune, to District Control Cell on January 30, 2020 as positive for COVID-19 infection. The details of basic laboratory investigations done on days 3, 7 and 20 of illness are shown in the Table. On day 1 of illness, the total white blood cell count was towards the low normal side, but on days 5 and 20, the count showed a rise which was consistent with a viral infection. Erythrocyte sedimentation rate was highest on day 7. The rest of the investigations were normal. She was referred to the Government Medical College, Thrissur, Kerala on January 31, 2020, and was admitted in isolation block designated for corona infection. By this time, the outbreak monitoring unit of the institution had brought out a detailed policy regarding the standard operating procedures including infection control measures to be followed in the isolation block. On presentation, she had only mild sore throat and rhinitis. She was conscious, oriented, afebrile, with pulse rate 76/min, blood pressure 100/70 mmHg, respiratory rate 12/min and oxygen saturation 97 per cent in the ambient air. General examination revealed no significant findings. She was started on oseltamivir and symptomatic measures. She gradually improved over the three days and became asymptomatic on February 3, 2020 and became negative for COVID-19 infection on day 19 of her illness. The oropharyngeal swabs for diagnosis of COVID-19 infection were collected on days 1, 4, 5, 7 and every alternate day, i.e. days 9, 11, 13 and so on after the onset of illness. The initial swabs remained positive till day 17 after which the swabs on days 19, 21 and 23 were negative and the patient was discharged. She was discharged from the hospital on February 20, 2020.
Table

Clinical laboratory report of the patient

MeasureDays of illness

151424
Haemoglobin (g/dl)10.812.212.111.3
Total WBC count (cells/μl)5300730074008500
Differential countPolymorphs-46Polymorphs-47Polymorphs-50-Polymorphs-56-
Lymphocytes-47Lymphocytes-42Lymphocytes-46Lymphocytes-36
Monocytes-7Monocytes-11Monocytes-4Monocytes-8
Platelet count (×106 cells/μl)2.883.633.9
ESR13443380
Urine routineNormalNormalNormalNormal
Random blood sugar (mg/dl)89828395
Blood urea (mg/dl)22141414
Serum creatinine (mg/dl)0.70.80.70.6
Serum sodium (mmol/l)136135134134
Serum potassium (mmol/l)4.34.44.24.3
Total bilirubin (mg/dl)0.70.40.50.4
Direct bilirubin (mg/dl)0.20.20.20.2
Total protein (g/dl)6.16.86.27.8
Serum albumin (g/dl)3.943.44.8
Alanine aminotransferase (IU/l)15131616
Aspartate aminotransferase (IU/l)19212322
Alkaline phosphatase (IU/l)113110116150

WBC, white blood cell; ESR, erythrocyte sedimentation rate

Clinical laboratory report of the patient WBC, white blood cell; ESR, erythrocyte sedimentation rate A detailed contact tracing was done by the Community Medicine department of the Government Medical College, Thrissur, with the District Health Authorities. Those identified were followed up for 28 days for any symptoms. All healthcare workers in the isolation block also were followed up for 14 days.
  1 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

  1 in total
  72 in total

1.  Lessons learnt during the first 100 days of COVID-19 pandemic in India.

Authors:  Rajesh Bhatia; Priya Abraham
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

2.  Hematological profiles of COVID-19 patients at the Ratlam district, Madhya Pradesh State, India.

Authors:  Reetesh Kumar Gujar; Anil Meena; Shailendra Singh Chouhan; K S Likhar
Journal:  Bioinformation       Date:  2021-07-31

3.  COVID-19 infection among health care workers: A hospital based study from Indian state of Meghalaya.

Authors:  Md Jamil; Prasanta K Bhattacharya; Bhupen Barman; Noor Topno; Naku Narang; Pranjal Phukan; Biswajit Dey; Bishwajeet Saikia; Gwenette Andrea War; Yasmeen Hynniewta
Journal:  J Family Med Prim Care       Date:  2022-05-14

4.  Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience.

Authors:  Maxwell Salvatore; Soumik Purkayastha; Lakshmi Ganapathi; Rupam Bhattacharyya; Ritoban Kundu; Lauren Zimmermann; Debashree Ray; Aditi Hazra; Michael Kleinsasser; Sunil Solomon; Ramnath Subbaraman; Bhramar Mukherjee
Journal:  Sci Adv       Date:  2022-06-17       Impact factor: 14.957

5.  Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.

Authors:  Shiv Lal Soni; Kamal Kajal; L N Yaddanapudi; Pankaj Malhotra; Goverdhan Dutt Puri; Ashish Bhalla; Mini P Singh; Inderpaul Singh Sehgal; Vipin Koushal; Neelam Varma; Manisha Biswal; P V M Lakshmi; Sadhna Sharma; Vikas Suri; Z Deepy; Sant Ram; Jaivinder Yadav; Navin Pandey; Prashant Sharma; Nabhajit Malik; Kapil Goyal; Aseem Mehra; Swapnajeet Sahoo; Ritin Mohindra; Jijo Francis; Mudit Bhargava; Karan Singla; Preena Babu; Amiy Verma; Niranjan Shiwaji Khaire; R R Guru
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

6.  The Impact of COVID-19 Pandemic on Orthopedic Trauma Practice: An Experience at a Tertiary Care Center in Northern India.

Authors:  Bhavkaran Singh; Rajesh Kapila; Kamalpreet Singh
Journal:  Cureus       Date:  2021-12-21

7.  Epidemiological profiles and associated risk factors of SARS-CoV-2 positive patients based on a high-throughput testing facility in India.

Authors:  Sumit Malhotra; Manju Rahi; Payal Das; Rini Chaturvedi; Jyoti Chhibber-Goel; Anup Anvikar; Hari Shankar; C P Yadav; Jaipal Meena; Shalini Tewari; Sudha V Gopinath; Reba Chhabra; Amit Sharma
Journal:  Open Biol       Date:  2021-06-02       Impact factor: 6.411

Review 8.  Connecting the dots: Kerala's use of digital technology during the COVID-19 response.

Authors:  Osama Ummer; Kerry Scott; Diwakar Mohan; Arpita Chakraborty; Amnesty Elizabeth LeFevre
Journal:  BMJ Glob Health       Date:  2021-07

9.  A cross-sectional study on COVID19 mortality among people below 30 years of age in Tamilnadu-2020.

Authors:  V Vijay Anand; G Arunkumar Yogaraj; S Priya; P Priya Raj; C Brinda Priyadharshini; P N Sridevi
Journal:  Clin Epidemiol Glob Health       Date:  2021-06-30

10.  Geo-prioritization framework for COVID-19 vaccine allocation in India.

Authors:  Akshay Mahajan; Jasmine Kaur; Chirag Sidana; Shashwat Shivam; Harpreet Singh
Journal:  Vaccine       Date:  2021-07-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.